Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction
Introduction
Progressive left ventricular remodeling after acute myocardial infarction is serious risk factor for cardiac death [1]. Previous studies have demonstrated that infarct size and persistent occlusion of the infarct-related coronary artery are two important factors that promote progressive ventricular dilatation 2, 3. These remodeling changes begin in the acute period and are progressive and may, occasionally, continue long after [4]. Therefore, early detection of left ventricular remodeling is important in the treatment of patients with acute myocardial infarction. There are several methods of quantifying the left ventricular remodeling such as left ventriculography [1], radionuclide ventriculogram [5], and echocardiography [6]. However, no single `gold-standard' noninvasive method for the evaluation of left ventricular remodeling has been established.
On the other hand, cardiac natriuretic peptides, atrial natriuretic peptide and brain natriuretic peptide are activated in the acute phase of acute myocardial infarction [7], and neurohumoral activation has often been regarded as a marker of compromised hemodynamic function. In addition, recent data suggest that some neurohormones may be prognostic indicators independent of signs of clinical heart failure and hemodynamic variables 8, 9. Omland et al. reported that brain natriuretic peptide provided significant prognostic information in patients after acute myocardial infarction [8]. However, it is not clear whether plasma atrial natriuretic peptide and brain natriuretic peptide levels are increased in the chronic phase of acute myocardial infarction, or whether these peptides correlate with left ventricular remodeling. In the present study, we evaluated the relationship between atrial natriuretic peptide and brain natriuretic peptide concentrations and left ventriculographic parameters in the early and chronic phase of acute myocardial infarction. We assessed the clinical value of neurohumoral evaluation as an indicator of left ventricular remodeling.
Section snippets
Subjects
We studied 33 Japanese patients with acute myocardial infarction (25 men, eight women) aged 40 to 80 years (mean age 59±11 years). A diagnosis of acute myocardial infarction was based on two of the three criteria: (1) typical ischemic chest pain lasting longer than 30 min, (2) electrocardiographic ST-segment elevation of 0.1 mV in 2 contiguous leads, (3) elevation of serum total creatine kinase and its MB isoenzyme to at least twice the upper limit of normal. We excluded patients with a history
Clinical characteristics and natriuretic peptide concentrations
Baseline characteristics are listed in Table 1. Fifteen patients had anterior infarction, and 18 had inferior infarction. Atrial natriuretic peptide and brain natriuretic peptide levels in the age- and sex-matched control subjects were 7±2 pg/ml and 6±2 pg/ml, respectively. Plasma atrial natriuretic peptide concentrations on admission, after 1 month and after 3 months were higher than those of the control group (P<0.05). Plasma brain natriuretic peptide concentrations on admission, after 1
Discussion
The present study demonstrates that atrial natriuretic peptide and brain natriuretic peptide concentrations are increased and correlate with left ventricular dilatation in the chronic phase of acute myocardial infarction. Thus, atrial natriuretic peptide and brain natriuretic peptide may be sensitive and useful biochemical markers of left ventricular remodeling in the chronic phase of acute myocardial infarction.
Acknowledgements
We thank Ms. Yoko Saito for technical assistance and Ms. Hiromi Hosaka for secretarial assistance.
References (21)
- et al.
Functional impact of remodeling during healing after non-Q-wave versus Q-wave anterior myocardial infarction in the dog
J Am Coll Cardiol
(1992) - et al.
Increased left ventricular volume following myocardial infarction in man
Am Heart J
(1986) - et al.
Thermodilution cardiac output: A critical analysis and review of the literature
J Surg Res
(1979) - et al.
Left ventricular volume and mass from single-plane angiogram: a comparison of anteroposterior and right anterior oblique methods
Am Heart J
(1970) - et al.
Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction
J Am Coll Cardiol
(1995) - et al.
Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction
J Am Coll Cardiol
(1995) - et al.
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction
Circulation
(1987) - et al.
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
Circulation
(1990) - et al.
Influence of chronic captopril therapy on the infarcted left ventricle of the rat
Circ Res
(1985) - et al.
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction
Circulation
(1994)
Cited by (17)
Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction
2012, American Journal of CardiologyCitation Excerpt :We included studies that reported LV volumes or LV diameters as indicators of LV remodeling. Because variability of the data reported (morphologic and biological variables on their original continuous scales or dichotomized into 2 groups) precluded a formal meta-analysis, relations between biomarkers and LV remodeling are presented in Table 1 as positive if a high level of the biomarker was significantly associated (p <0.05) with increased LV remodeling, negative if a low level of the biomarker was significantly associated (p <0.05) with increased LV remodeling, and none in the absence of any significant association.1–59 To visualize the association of a given biomarker with LV remodeling, data were grouped by biomarker; thus, publications that assessed >1 biomarker appear >1 time in Table 1.
Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease
2008, International Journal of CardiologyCitation Excerpt :To our knowledge, this is the first study analyzing the mid regional part of proatrial natriuretic peptide in comparison to NT-proBNP concerning left ventricular function in patients with a history of ST-elevation myocardial infarction. Data from recent clinical trials have shown that plasma levels of atrial natriuretic peptide (ANP) and N-terminal proatrial natriuretic peptide (NT-proANP) are persistently increased in patients with congestive heart failure and after myocardial infarction and are useful in detecting left ventricular dysfunction [5,9,10]. However, the stability and accuracy of ANP and NT-proANP might be inferior to that of MR-proANP.
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction
2004, Journal of the American College of CardiologyPlasma A- and B-type natriuretic peptides: Physiology, methodology and clinical use
2001, Cardiovascular ResearchNon-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
2016, International Journal of Cardiovascular ImagingThe usefulness of natriuretic peptides measurements in the diagnostics of chosen cardiovascular diseases
2013, Polski Merkuriusz Lekarski